Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Market Cap	1.76B
Revenue (ttm)	193.90M
Net Income (ttm)	4.82M
Shares Out	2.40M
EPS (ttm)	2.01
PE Ratio	364.10
Forward PE	n/a
Dividend	1.00 (0.14%)
Ex-Dividend Date	Nov 23, 2025

Volume	1,663
Average Volume	1,205
Open	741.00
Previous Close	747.50
Day's Range	730.00 - 741.00
52-Week Range	675.00 - 947.90
Beta	-0.39
RSI	32.24
Earnings Date	Jan 21, 2026

About Ambee Pharmaceuticals

Ambee Pharmaceuticals PLC engages in the manufacture, buy, sell, export, or deal in drugs, medicines, pharmaceuticals, chemicals, medical, and other preparations in Bangladesh. The company offers tablets, capsules, liquids, gel in tubes, and injectables for therapeutic areas, such as antiulcerant, antacid, antibacterial, antifungal, anti-protozoal, anti-helmintic, antituberculer, antispasmodic, antiasthmatic and antitussive, and analgesic and antipyretic. It also provides products for therapeutic areas in non-steroidal anti-inflammatory, steroi...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 474
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: AMBEEPHA

Financial Performance

In 2025, Ambee Pharmaceuticals's revenue was 230.55 million, an increase of 5.13% compared to the previous year's 219.30 million. Earnings were 5.31 million, a decrease of -45.17%.